Amoxycillin cap 250 mg,Ampicillin 250mg plus Cloxacillin 250mg Inj,Cefoperazonc Sodium inj 1 gm,Cef
Indian Army
Bid Publish Date
25-Jun-2025, 10:05 am
Bid End Date
16-Jul-2025, 11:00 am
EMD
₹790
Location
Progress
RAQuantity
356969
Category
Human Rabies Immune Globulin 150 IU slace ml,2 ml Vial
Bid Type
Two Packet Bid
A tender has been published for Indian Army Human Rabies Immune Globulin 150 IU slace ml, 2 ml Vial, Nitrofurantoin 100 mg Tab, Inj Clindamycin 150 mg slace ml, 2ml, Antacid chewable containing dried Aluminium Hydroxide IP 250 mg Mag Hydroxide NF 250 mg Methyl Polysiloxane 50 mg Tab, Levetiracetam 100mg slace ml, Vial of 5 ml inj, Carbimazole 5 mg Tab, Tetanus Human Immunoglobuline, Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg, Midazolam nasal spray0 point 5 mg slace spray 5 ml bottle, 2 Propanol 45gm, 1 Propanol 30 gm Ethyl hexadecyl dimethyl ammonium ethyl sulphate 0 point 2 gm with skin protecting substances 500 ml bott with dispenser, Clarithromycin 1 percent gel 15 gm Tube, Inj Nitroglycerine slace glyceryltrinitrate 5 mg, N Acetyl Cysteine 200 mg slace ml, 5 ml Ampoule, Calamine 8 percent with 10 percent light liquid paraffin 50 ml Bott, Tab Chlorzoxazone 500 mg plus Diclofenac 50mg and Paracetamol 325mg, Tab Dolutegravir 50 mg, Tab Thyroxin Sodium 12 point 5 mcg, Tab Thyroxin Sodium 75 mcg, Syp Sucralfate 1000 mg slace 10ml plus Oxetacaine 10 mg slace 10ml, bottle of 100 ml, Sacubitril 97mg plus Valsartan 103 mg tab, Syp Zinc 20mg slace 5ml bott of 100 ml, Human insulin analogue Glargine Recombinant DNA Origin 450 IU slace 1 point 5ml, PFS Disposable pen with 5 needles per pen, Inj Thiamine 100mg slace ml, 2ml Amp, Ciprofloxacin 500 mg Tab, Paracetamol 10 mg slace ml infusion in 100 ml bottls, Solifenacin 10 mg Tab, Alfuzosin 10 mg Tab, Rivaroxaban 20 mg Tab, Eplerenone 25mg Tab, Ranolazine 500 mg Tab, Nicorandil 5 mg Tab in KOLKATA, WEST BENGAL. Quantity: 356969 by. Submission Deadline: 16-07-2025 11: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
Indian Army
LEH, JAMMU & KASHMIR
Indian Army
LEH, JAMMU & KASHMIR
Indian Army
Dg Armed Forces Medical Service
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Human Rabies Immune Globulin 150 IU slace ml,2 ml Vial | Human Rabies Immune Globulin 150 IU/ml,2 ml Vial | 30 | vail | consignee2dglp | 30 |
| 2 | Nitrofurantoin 100 mg Tab | Nitrofurantoin 100 mg Tab | 40,000 | no | consignee2dglp | 30 |
| 3 | Inj Clindamycin 150 mg slace ml,2ml | Inj Clindamycin 150 mg/ml,2ml | 4,800 | amp slace vial | consignee2dglp | 30 |
| 4 | Antacid chewable containing dried Aluminium Hydroxide IP 250 mg Mag Hydroxide NF 250 mg Methyl Polysiloxane 50 mg Tab | Antacid (chewable) containing dried Aluminium Hydroxide IP 250 mg Mag Hydroxide NF 250 mg Methyl Polysiloxane 50 mg Tab | 7,605 | no | consignee2dglp | 30 |
| 5 | Levetiracetam 100mg slace ml, Vial of 5 ml inj | Levetiracetam 100mg/ml, Vial of 5 ml inj | 4,900 | vial | consignee2dglp | 30 |
| 6 | Carbimazole 5 mg Tab | Carbimazole 5 mg Tab | 33,000 | no | consignee2dglp | 30 |
| 7 | Tetanus Human Immunoglobuline | Tetanus Human Immunoglobuline. | 12 | no | consignee2dglp | 30 |
| 8 | Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg | Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCL 10 mg | 3,400 | no | consignee2dglp | 30 |
| 9 | Midazolam nasal spray0 point 5 mg slace spray 5 ml bottle | Midazolam nasal spray0.5 mg/spray 5 ml bottle | 462 | bott | consignee2dglp | 30 |
| 10 | 2 Propanol 45gm, 1 Propanol 30 gm Ethyl hexadecyl dimethyl ammonium ethyl sulphate 0 point 2 gm with skin protecting substances 500 ml bott with dispenser | 2 Propanol 45gm, 1 Propanol 30 gm Ethyl hexadecyl dimethyl ammonium ethyl sulphate 0.2 gm with skin protecting substances 500 ml bott with dispenser | 3,000 | bott | consignee2dglp | 30 |
| 11 | Clarithromycin 1 percent gel 15 gm Tube | Clarithromycin 1 percent gel 15 gm Tube | 690 | no | consignee2dglp | 30 |
| 12 | Inj Nitroglycerine slace glyceryltrinitrate 5 mg | Inj Nitroglycerine/ glyceryltrinitrate 5 mg | 2,800 | amp | consignee2dglp | 30 |
| 13 | N Acetyl Cysteine 200 mg slace ml, 5 ml Ampoule | N Acetyl Cysteine 200 mg/ml, 5 ml Ampoule | 546 | vial | consignee2dglp | 30 |
| 14 | Calamine 8 percent with 10 percent light liquid paraffin 50 ml Bott | Calamine 8 percent with 10 percent light liquid paraffin 50 ml Bott | 600 | bott | consignee2dglp | 30 |
| 15 | Tab Chlorzoxazone 500 mg plus Diclofenac 50mg and Paracetamol 325mg | Tab Chlorzoxazone 500 mg + Diclofenac 50mg and Paracetamol 325mg | 70,000 | no | consignee2dglp | 30 |
| 16 | Tab Dolutegravir 50 mg | Tab Dolutegravir 50 mg | 360 | no | consignee2dglp | 30 |
| 17 | Tab Thyroxin Sodium 12 point 5 mcg | Tab Thyroxin Sodium 12.5 mcg | 20,610 | no | consignee2dglp | 30 |
| 18 | Tab Thyroxin Sodium 75 mcg | Tab Thyroxin Sodium 75 mcg | 5,800 | no | consignee2dglp | 30 |
| 19 | Syp Sucralfate 1000 mg slace 10ml plus Oxetacaine 10 mg slace 10ml, bottle of 100 ml | Syp Sucralfate 1000 mg/ 10ml + Oxetacaine 10 mg/10ml, bottle of 100 ml | 2,280 | bott | consignee2dglp | 30 |
| 20 | Sacubitril 97mg plus Valsartan 103 mg tab | Sacubitril 97mg + Valsartan 103 mg tab | 31,800 | no | consignee2dglp | 30 |
| 21 | Syp Zinc 20mg slace 5ml bott of 100 ml | Syp Zinc 20mg/5ml bott of 100 ml | 690 | bott | consignee2dglp | 30 |
| 22 | Human insulin analogue Glargine Recombinant DNA Origin 450 IU slace 1 point 5ml, PFS Disposable pen with 5 needles per pen | Human insulin analogue Glargine (Recombinant DNA Origin) 450 IU/ 1.5ml, PFS Disposable pen with 5 needles per pen | 1,566 | pfs | consignee2dglp | 30 |
| 23 | Inj Thiamine 100mg slace ml, 2ml Amp | Inj Thiamine 100mg/ ml, 2ml Amp | 5,940 | amp | consignee2dglp | 30 |
| 24 | Ciprofloxacin 500 mg Tab | Ciprofloxacin 500 mg Tab | 12,878 | no | consignee2dglp | 30 |
| 25 | Paracetamol 10 mg slace ml infusion in 100 ml bottls | Paracetamol 10 mg/ml infusion in 100 ml bottls | 14,400 | bott | consignee2dglp | 30 |
| 26 | Solifenacin 10 mg Tab | Solifenacin 10 mg Tab | 8,000 | no | consignee2dglp | 30 |
| 27 | Alfuzosin 10 mg Tab | Alfuzosin 10 mg Tab | 5,000 | no | consignee2dglp | 30 |
| 28 | Rivaroxaban 20 mg Tab | Rivaroxaban 20 mg Tab | 1,800 | no | consignee2dglp | 30 |
| 29 | Eplerenone 25mg Tab | Eplerenone 25mg Tab | 10,000 | no | consignee2dglp | 30 |
| 30 | Ranolazine 500 mg Tab | Ranolazine 500 mg Tab | 16,000 | no | consignee2dglp | 30 |
| 31 | Nicorandil 5 mg Tab | Nicorandil 5 mg Tab | 48,000 | no | consignee2dglp | 30 |
Start
03-Sep-2025, 1:00 pm
End
11-Sep-2025, 1:00 pm
Duration: 192 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 27-06-2025 14:32:33 | Evaluated |
| 2 | ********** Under PMA | - | 13-07-2025 21:30:54 | Evaluated |
| 3 | ********** Under PMA | - | 15-07-2025 19:26:38 | Evaluated |
| 4 | ********** Under PMA | - | 16-07-2025 10:53:51 | Evaluated |
| 5 | ********** Under PMA | - | 02-07-2025 08:46:48 | Evaluated |
| 6 | ********** Under PMA | - | 15-07-2025 20:45:59 | Evaluated |
| 7 | ********** Under PMA | - | 16-07-2025 10:36:02 | Evaluated |
| 8 | ********** Under PMA | - | 15-07-2025 19:46:21 | Evaluated |
| 9 | ********** Under PMA | - | 15-07-2025 18:15:28 | Evaluated |
| 10 | ********** Under PMA | - | 09-07-2025 16:01:11 | Evaluated |
| 11 | ********** Under PMA | - | 16-07-2025 10:45:58 | Evaluated |
| 12 | ********** Under PMA | - | 15-07-2025 14:48:29 | Evaluated |
| 13 | ********** Under PMA | - | 16-07-2025 09:41:54 | Evaluated |
| 14 | ********** Under PMA | - | 15-07-2025 22:33:08 | Evaluated |
| 15 | ********** Under PMA | - | 16-07-2025 00:08:19 | Evaluated |
| 16 | ********** Under PMA | - | 15-07-2025 16:56:36 | Evaluated |
| 17 | ********** Under PMA | - | 16-07-2025 00:34:34 | Evaluated |
| 18 | ********** Under PMA | - | 16-07-2025 00:08:44 | Evaluated |
| 19 | ********** Under PMA | - | 15-07-2025 18:58:34 | Evaluated |
| 20 | ********** Under PMA | - | 16-07-2025 01:40:48 | Evaluated |
| 21 | ********** Under PMA | - | 14-07-2025 13:53:11 | Evaluated |
| 22 | ********** Under PMA | - | 14-07-2025 14:47:37 | Evaluated |
| 23 | ********** Under PMA | - | 27-06-2025 13:06:46 | Evaluated |
| 24 | ********** Under PMA | - | 15-07-2025 18:51:59 | Evaluated |
| 25 | ********** Under PMA | - | 16-07-2025 09:23:37 | Evaluated |
| 26 | ********** Under PMA | - | 15-07-2025 10:48:53 | Evaluated |
| 27 | ********** Under PMA | - | 15-07-2025 16:19:40 | Evaluated |
| 28 | ********** Under PMA | - | 11-07-2025 18:31:54 | Evaluated |
| 29 | ********** Under PMA | - | 15-07-2025 17:41:22 | Evaluated |
Key insights about WEST BENGAL tender market
The eligibility requirements include being a registered entity in the pharmaceutical sector. Bidders must comply with all relevant regulatory standards for medical supplies and must provide evidence of quality assurances for the products offered. Special consideration may be given to MSEs and start-ups, enhancing their opportunity to engage in this vital procurement process.
Bidders are required to submit several certificates, including manufacturing licenses and quality compliance certificates. These documents are essential to demonstrate adherence to pharmaceutical quality standards and ensure that all products meet the specified technical requirements outlined in the tender documentation.
Entities wishing to submit a bid must complete the online registration process via the designated procurement portal. This includes uploading necessary compliance documents and financial statements to meet the financial requirements specified in the tender description.
The Earnest Money Deposit (EMD) is a security measure ensuring that bidders have a serious intent to participate in the bidding process. The specific amount for the EMD will be detailed in the tender documents, and payment methods must conform to the instructions provided.
Bids will undergo evaluation based on compliance with technical specifications, financial offerings, and overall bidder experience. Results will be communicated to all bidders via the procurement portal, ensuring transparency and adherence to the evaluation process guidelines provided in the tender announcement.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS